NeonMind Biosciences Performance
| NMDBFDelisted Stock | USD 0.50 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.57, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, NeonMind Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding NeonMind Biosciences is expected to be smaller as well. NeonMind Biosciences right now secures a risk of 0.0%. Please verify NeonMind Biosciences information ratio, skewness, as well as the relationship between the Skewness and day median price , to decide if NeonMind Biosciences will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days NeonMind Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, NeonMind Biosciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 1170.00 | |
| Total Cashflows From Investing Activities | 389.1 K |
NeonMind |
NeonMind Biosciences Relative Risk vs. Return Landscape
If you would invest 50.00 in NeonMind Biosciences on September 23, 2024 and sell it today you would earn a total of 0.00 from holding NeonMind Biosciences or generate 0.0% return on investment over 90 days. NeonMind Biosciences is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than NeonMind, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
NeonMind Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NeonMind Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as NeonMind Biosciences, and traders can use it to determine the average amount a NeonMind Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| NMDBF |
Based on monthly moving average NeonMind Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeonMind Biosciences by adding NeonMind Biosciences to a well-diversified portfolio.
NeonMind Biosciences Fundamentals Growth
NeonMind Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of NeonMind Biosciences, and NeonMind Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NeonMind Pink Sheet performance.
| Return On Equity | -37.22 | |||
| Return On Asset | -1.88 | |||
| Operating Margin | 735.17 % | |||
| Current Valuation | 799.08 K | |||
| Shares Outstanding | 35.82 M | |||
| Price To Book | 12.19 X | |||
| Price To Sales | 18.10 X | |||
| EBITDA | (6.65 M) | |||
| Cash And Equivalents | 89.22 K | |||
| Total Debt | 450.01 K | |||
| Debt To Equity | 1.58 % | |||
| Book Value Per Share | (1.22) X | |||
| Cash Flow From Operations | (5.82 M) | |||
| Earnings Per Share | (0.14) X | |||
| Total Asset | 1.34 M | |||
About NeonMind Biosciences Performance
By analyzing NeonMind Biosciences' fundamental ratios, stakeholders can gain valuable insights into NeonMind Biosciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NeonMind Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NeonMind Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
NeonMind Biosciences Inc. engages in the discovery, development, and commercialization of medicinal and psychedelic mushrooms for mental illnesses. NeonMind Biosciences Inc. is a subsidiary of The Yield Growth Corp. Neonmind Biosciences is traded on OTC Exchange in the United States.Things to note about NeonMind Biosciences performance evaluation
Checking the ongoing alerts about NeonMind Biosciences for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for NeonMind Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NeonMind Biosciences is not yet fully synchronised with the market data | |
| NeonMind Biosciences has some characteristics of a very speculative penny stock | |
| NeonMind Biosciences has a very high chance of going through financial distress in the upcoming years | |
| NeonMind Biosciences has accumulated 450.01 K in total debt with debt to equity ratio (D/E) of 1.58, which is about average as compared to similar companies. NeonMind Biosciences has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist NeonMind Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, NeonMind Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NeonMind Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NeonMind to invest in growth at high rates of return. When we think about NeonMind Biosciences' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (7.21 M) with loss before overhead, payroll, taxes, and interest of (84.45 K). | |
| NeonMind Biosciences has accumulated about 89.22 K in cash with (5.82 M) of positive cash flow from operations. |
- Analyzing NeonMind Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NeonMind Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining NeonMind Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NeonMind Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of NeonMind Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NeonMind Biosciences' pink sheet. These opinions can provide insight into NeonMind Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in NeonMind Pink Sheet
If you are still planning to invest in NeonMind Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeonMind Biosciences' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance |